ViroPharma Incorporated Announces Base Share Amount and Auto-Conversion Price for its Plus Cash Notes
21 mai 2004 18h06 HE
|
ViroPharma Incorporated
EXTON, Pa., May 21, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by...
ViroPharma Appoints Colin Broom, M.D. Vice President and Chief Scientific Officer
11 mai 2004 07h34 HE
|
ViroPharma Incorporated
EXTON, Pa., May 11, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today that Colin Broom, M.D. has joined the company as vice president and chief scientific officer. Dr. Broom...
ViroPharma Incorporated Reports First Quarter 2004 Financial Results
04 mai 2004 07h35 HE
|
ViroPharma Incorporated
EXTON, Pa., May 4, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today financial results for the first quarter ended March 31, 2004.
Quarter ended March 31, 2004
For the...
ViroPharma Incorporated Commences Exchange Offer for its 6% Convertible Subordinated Notes Due 2007
28 avr. 2004 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., April 28, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by...
ViroPharma Announces Appointment of New Director of Corporate Communications
01 avr. 2004 10h00 HE
|
ViroPharma Incorporated
EXTON, Pa., April 1, 2004 (PRIMEZONE) -- ViroPharma, Inc. (Nasdaq:VPHM) announced today the appointment of William C. Roberts as director, corporate communications.
"As ViroPharma goes forward, it...
ViroPharma Announces Filing of Registration Statements for Proposed Exchange Offer with the Holders of its 6% Convertible Subordinated Notes Due 2007 and $25,000,000 New Money Notes Offering
19 mars 2004 18h46 HE
|
ViroPharma Incorporated
EXTON, Pa., March 19, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by...
ViroPharma Incorporated Enters Into Agreement in Principle to Settle Securities Litigation
17 mars 2004 09h30 HE
|
ViroPharma Incorporated
EXTON, Pa., March 17, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has entered into an agreement in principle to settle its current class action securities...
ViroPharma Incorporated Reports 2003 Financial Results
25 févr. 2004 08h57 HE
|
ViroPharma Incorporated
EXTON, Pa., Feb. 25, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today financial results for the fourth quarter and the year ended December 31, 2003.
Quarter ended December...
ViroPharma Initiates Phase 1 Hepatitis C Program With HCV-086
24 févr. 2004 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., Feb. 24, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the initiation of a phase 1 clinical program with HCV-086, a hepatitis C antiviral compound that the...
ViroPharma Initiates Clinical Program with Maribavir for Prevention of Cytomegalovirus (CMV) Infection in Transplant Patients
05 févr. 2004 07h45 HE
|
ViroPharma Incorporated
EXTON, Pa., Feb. 5, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the initiation of a clinical program to develop maribavir, an oral antiviral drug that inhibits...